Pham A, Ghilardi A, Sun L
Front Pharmacol. 2023; 14:1127722.
PMID: 36959850
PMC: 10028200.
DOI: 10.3389/fphar.2023.1127722.
Zhang H, Ma Y, Zhang Q, Liu R, Luo H, Wang X
BMC Med Genomics. 2022; 15(1):97.
PMID: 35473583
PMC: 9040268.
DOI: 10.1186/s12920-022-01239-3.
Wu X, Lin L, Qin J, Wang L, Wang H, Zou Y
J Am Heart Assoc. 2020; 9(9):e014920.
PMID: 32349637
PMC: 7428569.
DOI: 10.1161/JAHA.119.014920.
Gao C, Chen J, Fan F, Long Y, Tang S, Jiang C
Mediators Inflamm. 2019; 2019:6207563.
PMID: 31485193
PMC: 6710801.
DOI: 10.1155/2019/6207563.
Ellwanger K, Briese S, Arnold C, Kienes I, Heim V, Nachbur U
Life Sci Alliance. 2019; 2(4).
PMID: 31350258
PMC: 6660644.
DOI: 10.26508/lsa.201900346.
Harnessing the untapped potential of nucleotide-binding oligomerization domain ligands for cancer immunotherapy.
Nabergoj S, Mlinaric-Rascan I, Jakopin Z
Med Res Rev. 2018; 39(5):1447-1484.
PMID: 30548868
PMC: 6767550.
DOI: 10.1002/med.21557.
Structural basis of RIP2 activation and signaling.
Gong Q, Long Z, Zhong F, Teo D, Jin Y, Yin Z
Nat Commun. 2018; 9(1):4993.
PMID: 30478312
PMC: 6255760.
DOI: 10.1038/s41467-018-07447-9.
CARD domain of rat RIP2 kinase: Refolding, solution structure, pH-dependent behavior and protein-protein interactions.
Goncharuk S, Artemieva L, Tabakmakher V, Arseniev A, Mineev K
PLoS One. 2018; 13(10):e0206244.
PMID: 30352081
PMC: 6198988.
DOI: 10.1371/journal.pone.0206244.
RIP2 Is a Critical Regulator for NLRs Signaling and MHC Antigen Presentation but Not for MAPK and PI3K/Akt Pathways.
Wu X, Chen W, Hu Y, Cao L, Nie P, Chang M
Front Immunol. 2018; 9:726.
PMID: 29692779
PMC: 5903030.
DOI: 10.3389/fimmu.2018.00726.
RNAi screen reveals a role of SPHK2 in dengue virus-mediated apoptosis in hepatic cell lines.
Morchang A, Lee R, Yenchitsomanus P, Sreekanth G, Noisakran S, Chu J
PLoS One. 2017; 12(11):e0188121.
PMID: 29145490
PMC: 5690425.
DOI: 10.1371/journal.pone.0188121.
Structures of the inactive and active states of RIP2 kinase inform on the mechanism of activation.
Pellegrini E, Signor L, Singh S, Boeri Erba E, Cusack S
PLoS One. 2017; 12(5):e0177161.
PMID: 28545134
PMC: 5436651.
DOI: 10.1371/journal.pone.0177161.
The cyclin-like protein, SPY1, regulates the ERα and ERK1/2 pathways promoting tamoxifen resistance.
Ferraiuolo R, Tubman J, Sinha I, Hamm C, Porter L
Oncotarget. 2017; 8(14):23337-23352.
PMID: 28423577
PMC: 5410308.
DOI: 10.18632/oncotarget.15578.
Dual Inhibition of Rip2 and IRAK1/4 Regulates IL-1β and IL-6 in Sarcoidosis Alveolar Macrophages and Peripheral Blood Mononuclear Cells.
Talreja J, Talwar H, Ahmad N, Rastogi R, Samavati L
J Immunol. 2016; 197(4):1368-78.
PMID: 27402699
PMC: 4975961.
DOI: 10.4049/jimmunol.1600258.
The MST/Hippo Pathway and Cell Death: A Non-Canonical Affair.
Fallahi E, ODriscoll N, Matallanas D
Genes (Basel). 2016; 7(6).
PMID: 27322327
PMC: 4929427.
DOI: 10.3390/genes7060028.
A Phosphoproteomic Comparison of B-RAFV600E and MKK1/2 Inhibitors in Melanoma Cells.
Stuart S, Houel S, Lee T, Wang N, Old W, Ahn N
Mol Cell Proteomics. 2015; 14(6):1599-615.
PMID: 25850435
PMC: 4458723.
DOI: 10.1074/mcp.M114.047233.
RIP kinases: key decision makers in cell death and innate immunity.
Humphries F, Yang S, Wang B, Moynagh P
Cell Death Differ. 2014; 22(2):225-36.
PMID: 25146926
PMC: 4291486.
DOI: 10.1038/cdd.2014.126.
NOD-Like Receptors: Master Regulators of Inflammation and Cancer.
Saxena M, Yeretssian G
Front Immunol. 2014; 5:327.
PMID: 25071785
PMC: 4095565.
DOI: 10.3389/fimmu.2014.00327.
Receptor-interacting protein kinase 2 promotes triple-negative breast cancer cell migration and invasion via activation of nuclear factor-kappaB and c-Jun N-terminal kinase pathways.
Singel S, Batten K, Cornelius C, Jia G, Fasciani G, Barron S
Breast Cancer Res. 2014; 16(2):R28.
PMID: 24642040
PMC: 4053227.
DOI: 10.1186/bcr3629.
A genome-scale RNA interference screen implicates NF1 loss in resistance to RAF inhibition.
Whittaker S, Theurillat J, Van Allen E, Wagle N, Hsiao J, Cowley G
Cancer Discov. 2013; 3(3):350-62.
PMID: 23288408
PMC: 3606893.
DOI: 10.1158/2159-8290.CD-12-0470.
The EGF receptor and HER2 participate in TNF-α-dependent MAPK activation and IL-8 secretion in intestinal epithelial cells.
Jijon H, Buret A, Hirota C, Hollenberg M, Beck P
Mediators Inflamm. 2012; 2012:207398.
PMID: 22988345
PMC: 3440955.
DOI: 10.1155/2012/207398.